Title : Analysis of the MILES cohort reveals determinants of disease progression and treatment response in lymphangioleiomyomatosis.

Pub. Date : 2019 Apr

PMID : 30846465






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Baseline serum vascular endothelial growth factor (VEGF)-D >600 pg mL-1 identified subgroups of patients who were more likely to decline on placebo and respond to treatment with sirolimus. Sirolimus vascular endothelial growth factor A Homo sapiens
2 Baseline serum vascular endothelial growth factor (VEGF)-D >600 pg mL-1 identified subgroups of patients who were more likely to decline on placebo and respond to treatment with sirolimus. Sirolimus vascular endothelial growth factor A Homo sapiens